Last Updated on September 8, 2020 by admin
Russia approved the public use of coronavirus vaccine Sputnik V. The first batch of vaccine has been released for civil circulation. COVID-19 vaccine Sputnik V supply to Russian regions is expected soon said in a report citing the Russian Ministry of Health.
The vaccine, developed by Moscow’s Gamaleya National Research Centre of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF)on August 11 was registered by the Russian health ministry, the first vaccine against COVID-19. It has been named Sputnik V.
A few days ago, Russian Health Minister Mikhail Murashko proclaimed that the vaccine for coronavirus treatment had completed the final phase of clinical trials and showed extensive effectiveness. He also said that the government will first vaccinate teachers and doctors and then launch it nationwide.
On September 4, Russian Scientists published the first result from early trials into Sputnik V vaccine. They tested dozens of people before being more widely administered. Two trials of Sputnik-V were conducted in June-July this year.
In a report published in the journal Lancet, it is found that the vaccine is safe, well-tolerated, tested on 40 people in the second phase of the study, said by vaccine developers. The author noted that people were only followed for 42 days, the study sample was small and no Placebo used.
In the analysis, Russian researchers reported that the safety test included only men between the ages of 20 and 30. So, it is quite unclear that the vaccine might work in older population who are most affected due to coronavirus COVID-19.